$HZNP Horizon Therapeutics Public Ltd Co Insider Trading Week 18/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Horizon Therapeutics Public Ltd Co.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Horizon Therapeutics Public Ltd Co in week 18/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 04 2017 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | A | 0.00 | 14,054 | 0 | 14,054 | |
| May 04 2017 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | A | 15.12 | 31,153 | 471,033 | 31,153 | |
| May 04 2017 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | M | 0.00 | 13,953 | 0 | 0 | |
| May 04 2017 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Buy | M | 0.00 | 13,953 | 0 | 19,211 | 5.3 K to 19.2 K (+265.37 %) |
| May 04 2017 | HZNP | Horizon Pharma plc | Nohria Virinder | Director | Option Exercise | A | 0.00 | 14,054 | 0 | 14,054 | |
| May 04 2017 | HZNP | Horizon Pharma plc | Nohria Virinder | Director | Option Exercise | A | 15.12 | 31,153 | 471,033 | 31,153 | |
| May 04 2017 | HZNP | Horizon Pharma plc | Nohria Virinder | Director | Option Exercise | M | 0.00 | 13,953 | 0 | 0 | |
| May 04 2017 | HZNP | Horizon Pharma plc | Nohria Virinder | Director | Buy | M | 0.00 | 13,953 | 0 | 19,211 | 5.3 K to 19.2 K (+265.37 %) |
| May 04 2017 | HZNP | Horizon Pharma plc | SANTINI GINO | Director | Option Exercise | A | 0.00 | 14,054 | 0 | 14,054 | |
| May 04 2017 | HZNP | Horizon Pharma plc | SANTINI GINO | Director | Option Exercise | A | 15.12 | 31,153 | 471,033 | 31,153 | |
| May 04 2017 | HZNP | Horizon Pharma plc | SANTINI GINO | Director | Option Exercise | M | 0.00 | 13,953 | 0 | 0 | |
| May 04 2017 | HZNP | Horizon Pharma plc | SANTINI GINO | Director | Payment of Exercise | F | 15.12 | 5,477 | 82,812 | 12,316 | 17.8 K to 12.3 K (-30.78 %) |
| May 04 2017 | HZNP | Horizon Pharma plc | SANTINI GINO | Director | Buy | M | 0.00 | 13,953 | 0 | 17,793 | 3.8 K to 17.8 K (+363.36 %) |
| May 04 2017 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Option Exercise | A | 0.00 | 14,054 | 0 | 14,054 | |
| May 04 2017 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Option Exercise | A | 15.12 | 31,153 | 471,033 | 31,153 | |
| May 04 2017 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Option Exercise | M | 0.00 | 13,953 | 0 | 0 | |
| May 04 2017 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Payment of Exercise | F | 15.12 | 3,763 | 56,897 | 14,030 | 17.8 K to 14 K (-21.15 %) |
| May 04 2017 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Buy | M | 0.00 | 13,953 | 0 | 17,793 | 3.8 K to 17.8 K (+363.36 %) |
| May 04 2017 | HZNP | Horizon Pharma plc | Himawan Jeff | Director | Option Exercise | A | 0.00 | 14,054 | 0 | 14,054 | |
| May 04 2017 | HZNP | Horizon Pharma plc | Himawan Jeff | Director | Option Exercise | A | 15.12 | 31,153 | 471,033 | 31,153 | |
| May 04 2017 | HZNP | Horizon Pharma plc | Himawan Jeff | Director | Option Exercise | M | 0.00 | 13,953 | 0 | 0 | |
| May 04 2017 | HZNP | Horizon Pharma plc | Himawan Jeff | Director | Payment of Exercise | F | 15.12 | 3,763 | 56,897 | 10,190 | 14 K to 10.2 K (-26.97 %) |
| May 04 2017 | HZNP | Horizon Pharma plc | Himawan Jeff | Director | Buy | M | 0.00 | 13,953 | 0 | 13,953 | 0 to 14 K |
| May 04 2017 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | A | 0.00 | 14,054 | 0 | 14,054 | |
| May 04 2017 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | A | 15.12 | 31,153 | 471,033 | 31,153 | |
| May 04 2017 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | M | 0.00 | 13,953 | 0 | 0 | |
| May 04 2017 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Payment of Exercise | F | 15.12 | 3,763 | 56,897 | 15,448 | 19.2 K to 15.4 K (-19.59 %) |
| May 04 2017 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Buy | M | 0.00 | 13,953 | 0 | 19,211 | 5.3 K to 19.2 K (+265.37 %) |
| May 04 2017 | HZNP | Horizon Pharma plc | Daniel William F | Director | Option Exercise | A | 0.00 | 14,054 | 0 | 14,054 | |
| May 04 2017 | HZNP | Horizon Pharma plc | Daniel William F | Director | Option Exercise | A | 15.12 | 31,153 | 471,033 | 31,153 | |
| May 04 2017 | HZNP | Horizon Pharma plc | Daniel William F | Director | Option Exercise | M | 0.00 | 13,953 | 0 | 0 | |
| May 04 2017 | HZNP | Horizon Pharma plc | Daniel William F | Director | Payment of Exercise | F | 15.12 | 4,219 | 63,791 | 24,388 | 28.6 K to 24.4 K (-14.75 %) |
| May 04 2017 | HZNP | Horizon Pharma plc | Daniel William F | Director | Buy | M | 0.00 | 13,953 | 0 | 28,607 | 14.7 K to 28.6 K (+95.22 %) |